Şirket hakkında

Flow-FX provides precision delivery of biologics to injured bone will significantly improve patient outcomes. Flow-FX’s patented technologies are designed to improve fracture care at a time when osteoporotic and complex, non-healing fractures are on the rise. Under the continued guidance of Flow-FX founder, Patrick Sweeney, MD, Flow-FX is poised to become the leader in an increasingly critical market.

US
Doğrulanmamış şirket